Literature DB >> 12490063

Accurate determination of ataxin-2 polyglutamine expansion in patients with intermediate-range repeats.

Jennifer Hussey1, Paul J Lockhart, William Seltzer, Zbigniew K Wszolek, Haydeh Payami, Melissa Hanson, Katrina Gwinn-Hardy, Matt Farrer.   

Abstract

Spinocerebellar ataxia, type 2 (SCA2), results from an expansion of a stretch of polyglutamine repeats within the coding sequence of the ataxin-2 gene (ATX2), localized to chromosome 12q23-24. Recent studies have widened the clinical phenotype, notably for individuals with repeats of intermediate size, from 32 to 35 glutamine residues. This narrow range necessitates precise determination of repeat size. Diagnostic laboratories most often perform direct genotyping of ATX2 from polymerase chain-amplified patient DNA with subsequent sizing utilizing slab gel polyacrylamide gel electrophoresis (PAGE) or capillary electrophoresis. Using cloning and sequencing methods, we have constructed a ladder of ATX2 alleles of known size and sequence composition. This freely available size ladder will facilitate future quantification of expansions of the ATX2 locus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12490063     DOI: 10.1089/109065702761403397

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  5 in total

1.  Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias.

Authors:  Jorge Sequeiros; Sara Seneca; Joanne Martindale
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

2.  Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism.

Authors:  A Krygowska-Wajs; J M Kachergus; M M Hulihan; M J Farrer; J A Searcy; J Booij; H W Berendse; E Ch Wolters; Z K Wszolek
Journal:  J Neural Transm (Vienna)       Date:  2005-03-23       Impact factor: 3.575

3.  ATXN-2 CAG repeat expansions are interrupted in ALS patients.

Authors:  Lucia Corrado; Letizia Mazzini; Gaia Donata Oggioni; Bernadetta Luciano; Michela Godi; Alfredo Brusco; Sandra D'Alfonso
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

4.  Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.

Authors:  Lisa Wang; Jan O Aasly; Grazia Annesi; Soraya Bardien; Maria Bozi; Alexis Brice; Jonathan Carr; Sun J Chung; Carl Clarke; David Crosiers; Angela Deutschländer; Gertrud Eckstein; Matthew J Farrer; Stefano Goldwurm; Gaetan Garraux; Georgios M Hadjigeorgiou; Andrew A Hicks; Nobutaka Hattori; Christine Klein; Beom Jeon; Yun J Kim; Suzanne Lesage; Juei-Jueng Lin; Timothy Lynch; Peter Lichtner; Anthony E Lang; Vincent Mok; Barbara Jasinska-Myga; George D Mellick; Karen E Morrison; Grzegorz Opala; Lasse Pihlstrøm; Peter P Pramstaller; Sung S Park; Aldo Quattrone; Ekaterina Rogaeva; Owen A Ross; Leonidas Stefanis; Joanne D Stockton; Peter A Silburn; Jessie Theuns; Eng K Tan; Hiroyuki Tomiyama; Mathias Toft; Christine Van Broeckhoven; Ryan J Uitti; Karin Wirdefeldt; Zbigniew Wszolek; Georgia Xiromerisiou; Kuo-Chu Yueh; Yi Zhao; Thomas Gasser; Demetrius M Maraganore; Rejko Krüger; Manu Sharma
Journal:  Neurology       Date:  2015-09-09       Impact factor: 9.910

Review 5.  Structural Characteristics of Simple RNA Repeats Associated with Disease and their Deleterious Protein Interactions.

Authors:  Adam Ciesiolka; Magdalena Jazurek; Karolina Drazkowska; Wlodzimierz J Krzyzosiak
Journal:  Front Cell Neurosci       Date:  2017-04-11       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.